Wednesday, October 14, 2026
ExploreSearch
Finance Via News
Via News Knowledge File

New York Stock Exchange

organization80% conf.·synced Oct 14, 2026

Stock exchange where The Hartford is listed

5
sourced metrics
1512
relationships
11
stated objectives
2
Via News reports

Every fact below is drawn from Via News's knowledge graph and linked to the source document it came from. Nothing here is unsourced. How we source →

Key metrics · each point sourced

Trading Days
5days_per_week
source
Trading Hours
6.5hours_per_day
source
Closing Auction Notional Value
230.5USD
Mar 27, 2026source
Closing Auction Shares Traded
3.57billion_shares
Mar 27, 2026source
Average Holding Period
5.5months
Jan 1, 2020⚠ sources conflictsource

Stated objectives

Enable 24/7 trading through stock tokenization

source
stated

Launch blockchain-powered platform enabling 24/7 trading of tokenized stocks and ETFs

source
target: 24/7 trading availability by 2025-01-01 00:00:00stated

Develop digital transfer agent program to support on-chain settlement of tokenized security transactions

source
stated

Collaborate on development of standards for digital transfer agents and tokenization agents participating in the digital ecosystem, focusing on regulatory, operational, and technology requirements for institutional-grade tokenized securities infrastructure

source
stated

Develop digital transfer agent program to support on-chain settlement of tokenized security transactions

source
stated

Develop standards for digital transfer agents and tokenization agents participating in the digital ecosystem, focusing on regulatory, operational, and technology requirements for institutional-grade tokenized securities infrastructure

source
stated

Develop digital transfer agent program to support on-chain settlement of tokenized security transactions

source
stated

Collaborate on development of standards for digital transfer agents and tokenization agents, establishing regulatory, operational, and technology requirements for institutional-grade tokenized securities infrastructure

source
stated

Supporting tokenized stocks and ETFs within existing market infrastructure

source
stated

Build a blockchain venue allowing trading of tokenized stocks and ETFs around the clock

source
stated

Relationship graph · 1512 connections

listed on
1049
located in
307
trades on
40
regulates
22
Employs
12
subsidiary of
8
Owns
8
Covered by
7
Built on
Blockchain
Customer of
AEVEX Corp.

Via News coverage

MPLX Plans 400,000 bpd LPG Export Terminal on Gulf Coast for 2028 Launch
February 21, 2026
Aegon to Redomicile as Transamerica Inc. by 2028 in Major Strategic Pivot to US
February 18, 2026
This Knowledge File is assembled from Via News's source-traceable knowledge graph. Metrics, objectives and relationships are extracted from primary and credible secondary documents and refreshed on a schedule. Read our methodology →
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Clinical Catalyst Season: Big-Pharma Data Flow, Regulatory Milestones, and a Thin AI-Drug Fringe
October 2026 conferences (EASD, IGCS, NACFC, HFSA) are producing a dense run of late-stage readouts from Novo Nordisk, Lilly, Roche, Bayer, Vertex and Galderma. Regulatory milestones are scheduled behind them: the ivonescimab BLA PDUFA date on 2026-11-14, FDA acceptance of Roche's vamikibart BLA, and Scholar Rock's EMA resubmission. The AI-and-finance angle is peripheral. It consists of the AI-designed drug Rentosertib and QAIAx, a speculative microcap whose trial claims (the QIII pilot, anticipated 2027-01-01, and a patent update) are forecasts and filings rather than data, so they warrant skepticism.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,375 source documents archived
Query this data → isubstrate.com